We are live on !
Find out more
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter Est. Return
+29.51%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$16.3B
AUM Growth
+$2.23B
(+16%)
Cap. Flow
-$15.3M
Cap. Flow % of AUM
Cap. Flow %
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
37.34%
Holding
1,883
New
197
Increased
1,009
Reduced
634
Closed
42
Avg Time Held
3.4
years
Top 10 Avg Time Held
4.7
years
Top 20 Avg Time Held
3.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$80.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$76.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$57.8M |
| 4 |
Caterpillar
CAT
|
+$32.2M |
| 5 |
Applied Materials
AMAT
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$149M |
| 2 |
Amazon
AMZN
|
+$128M |
| 3 |
Microsoft
MSFT
|
+$121M |
| 4 |
AbbVie
ABBV
|
+$34.6M |
| 5 |
Costco
COST
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.2% |
| 2 | Communication Services | 10.83% |
| 3 | Financials | 10.29% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1601
Astrana Health
ASTH
$1.83B
| $203K | ﹤0.01% |
+4,375
| New | +$157K |
2026 Q2
0 quarters
|
|
1602
Perdoceo Education
PRDO
$2.12B
| $203K | ﹤0.01% |
6,331
+260
| +4% | +$8.92K |
2026 Q1
1 quarter
|
|
1603
Universal Technical Institute
UTI
$1.14B
| $203K | ﹤0.01% |
+4,736
| New | +$182K |
2026 Q2
0 quarters
|
|
1604
MasterBrand
MBC
$1.35B
| $202K | ﹤0.01% |
19,674
+7,992
| +68% | +$68.2K |
2025 Q3
3 quarters
|
|
1605
Agnico Eagle Mines
AEM
$95B
| $202K | ﹤0.01% |
+1,304
| New | +$242K |
2026 Q2
0 quarters
|
|
1606
First Commonwealth Financial
FCF
$2.05B
| $202K | ﹤0.01% |
9,943
-183
| -2% | -$3.46K |
2026 Q1
1 quarter
|
|
1607
Acadian Asset Management
AAMI
$3.3B
| $201K | ﹤0.01% |
+2,815
| New | +$196K |
2026 Q2
0 quarters
|
|
1608
Braze
BRZE
$3.38B
| $200K | ﹤0.01% |
+9,233
| New | +$206K |
2026 Q2
0 quarters
|
|
1609
Bitdeer Technologies
BTDR
$2.19B
| $200K | ﹤0.01% |
12,610
+2,169
| +21% | +$31.1K |
2026 Q1
1 quarter
|
|
1610
NovaGold Resources
NG
$2.87B
| $200K | ﹤0.01% |
33,418
+6,951
| +26% | +$57.8K |
2021 Q2
20 quarters
|
|
1611
Eos Energy Enterprises
EOSE
$670M
| $199K | ﹤0.01% |
33,839
+5,586
| +20% | +$38.8K |
2025 Q2
4 quarters
|
|
1612
Diversified Healthcare Trust
DHC
$1.81B
| $199K | ﹤0.01% |
21,380
+1,280
| +6% | +$10.5K |
2021 Q2
20 quarters
|
|
1613
Aurinia Pharmaceuticals
AUPH
$2.2B
| $199K | ﹤0.01% |
11,707
+760
| +7% | +$12.1K |
2026 Q1
1 quarter
|
|
1614
Lifestance Health
LFST
$4.48B
| $198K | ﹤0.01% |
18,472
+3,205
| +21% | +$24.8K |
2025 Q1
5 quarters
|
|
1615
Quantum Computing Inc
QUBT
$1.48B
| $196K | ﹤0.01% |
20,171
+1,736
| +9% | +$16.9K |
2025 Q3
3 quarters
|
|
1616
Klaviyo
KVYO
$4.96B
| $195K | ﹤0.01% |
+12,933
| New | +$214K |
2026 Q2
0 quarters
|
|
1617
Ocular Therapeutix
OCUL
$1.36B
| $194K | ﹤0.01% |
19,745
+2,638
| +15% | +$23.9K |
2024 Q3
7 quarters
|
|
1618
JetBlue
JBLU
$1.12B
| $193K | ﹤0.01% |
33,717
+6,573
| +24% | +$33.5K |
2020 Q2
24 quarters
|
|
1619
Trevi Therapeutics
TRVI
$1.68B
| $191K | ﹤0.01% |
+10,257
| New | +$149K |
2026 Q2
0 quarters
|
|
1620
Neogen
NEOG
$2.57B
| $191K | ﹤0.01% |
21,263
+604
| +3% | +$5.54K |
2020 Q4
22 quarters
|
|
1621
Biohaven
BHVN
$1.71B
| $190K | ﹤0.01% |
12,794
+2,725
| +27% | +$29.3K |
2026 Q1
1 quarter
|
|
1622
Kohl's
KSS
$2.47B
| $189K | ﹤0.01% |
10,662
+638
| +6% | +$9.46K |
2026 Q1
1 quarter
|
|
1623
Douglas Emmett
DEI
$1.61B
| $189K | ﹤0.01% |
16,004
+297
| +2% | +$3.34K |
2024 Q2
8 quarters
|
|
1624
ADMA Biologics
ADMA
$2.48B
| $187K | ﹤0.01% |
22,363
+458
| +2% | +$4.18K |
2022 Q2
16 quarters
|
|
1625
Recursion Pharmaceuticals
RXRX
$1.96B
| $185K | ﹤0.01% |
50,397
+9,151
| +22% | +$30.5K |
2024 Q2
8 quarters
|
|
Similar funds
NMO
Xponance's Q2 2026 Portfolio in Review
As of Q2 2026, Xponance held 1,883 positions worth $16.3B, up 16% from $14.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Xponance's Q2 2026 filing shows 197 new, 1,009 increased, 634 reduced and 42 closed positions. Its largest new stake was SpaceX: 114,259 shares worth $19.5M. The largest sale was Apple, an estimated $149M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Communication Services and Financials.
- Xponance's largest Q2 2026 buy was SpaceX: 114,259 shares worth $19.5M.
- Xponance added most to Micron Technology in Q2 2026, an estimated $80.6M increase.
- Xponance's biggest Q2 2026 reduction was Apple, cutting an estimated $149M.
- Xponance fully exited Coterra Energy in Q2 2026, selling an estimated $4.27M.
- Xponance's ten largest holdings make up 37% of its $16.3B portfolio in Q2 2026.
- Xponance opened 197 new positions and closed 42 in Q2 2026.
- Xponance's portfolio value rose 16% quarter-over-quarter to $16.3B.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.